David Goeddel V - 29 May 2025 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: TNYA
Reported as of: 29 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 May 2025, 18:52:21 UTC
Prior SEC filing: 07 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact

Key filing fact

David Goeddel V filed Form 4 for Tenaya Therapeutics, Inc. (TNYA) on 30 May 2025.

Key facts

This page summarizes David Goeddel V's Form 4 filing for Tenaya Therapeutics, Inc. (TNYA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 30 May 2025, 18:52.

Change

Previous filing in this sequence was filed on 07 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001182464 Primary reporting owner

GOEDDEL DAVID V

Relationship: Director, 10%+ Owner
Address: C/O TENAYA THERAPEUTICS, INC., 171 OYSTER POINT BLVD., 5TH FLOOR, SOUTH SAN FRANCISCO
Signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Signature date: 30 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TNYA transaction Derivative

Stock Option (Right to buy)

Award

Transaction value: $0
Shares: +107,400
Change %
Price: $0.000000
Shares after: 107,400
Date: 29 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 107,400
Exercise price: $0.4444
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 29, 2026, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.